TY - JOUR
T1 - Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica
AU - Akaishi, Tetsuya
AU - Kaneko, Kimihiko
AU - Himori, Noriko
AU - Takeshita, Takayuki
AU - Takahashi, Toshiyuki
AU - Nakazawa, Toru
AU - Aoki, Masashi
AU - Nakashima, Ichiro
N1 - Publisher Copyright:
© 2017 Elsevier B.V.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2017/12/15
Y1 - 2017/12/15
N2 - We compared the retinal thickness in the unaffected eyes among the following subtypes of unilateral optic neuritis (ON): multiple sclerosis (MS-ON), neuromyelitis optica spectrum disorder with anti-AQP4 autoantibody (AQP4-ON), patients with serum anti-MOG antibody (MOG-ON), and idiopathic ON. In the chronic phase, macular GCC and circum-papillary RNFL in the unaffected eyes were both atrophied in MS-ON and AQP4-ON, but were not atrophied in the others. Titers of anti-AQP4-Ab was suggested to be associated with such latent neurodegenerative process in AQP4-ON. Long-term follow up of OCT is recommended even in the unaffected side in MS-ON and AQP4-ON.
AB - We compared the retinal thickness in the unaffected eyes among the following subtypes of unilateral optic neuritis (ON): multiple sclerosis (MS-ON), neuromyelitis optica spectrum disorder with anti-AQP4 autoantibody (AQP4-ON), patients with serum anti-MOG antibody (MOG-ON), and idiopathic ON. In the chronic phase, macular GCC and circum-papillary RNFL in the unaffected eyes were both atrophied in MS-ON and AQP4-ON, but were not atrophied in the others. Titers of anti-AQP4-Ab was suggested to be associated with such latent neurodegenerative process in AQP4-ON. Long-term follow up of OCT is recommended even in the unaffected side in MS-ON and AQP4-ON.
KW - Multiple sclerosis
KW - Myelin oligodendrocyte glycoprotein
KW - Neuromyelitis optica
KW - Optic coherence tomography
KW - Unaffected side
UR - http://www.scopus.com/inward/record.url?scp=85030873503&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030873503&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2017.10.001
DO - 10.1016/j.jneuroim.2017.10.001
M3 - Article
C2 - 29153600
AN - SCOPUS:85030873503
SN - 0165-5728
VL - 313
SP - 10
EP - 15
JO - Advances in Neuroimmunology
JF - Advances in Neuroimmunology
ER -